FDA Inspection 887267 — New Jersey Laboratories

New Jersey Laboratories — FEI 2219935

The FDA completed an inspection of New Jersey Laboratories on July 9, 2014 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 9, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Brunswick, NJ (United States)